| Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia K Nemes, M Csóka, N Nagy, Á Márk, Z Váradi, T Dankó, G Kovács, ... Pathology & Oncology Research 21, 597-604, 2015 | 71 | 2015 |
| Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease–a combined tissue microarray, in vitro and in vivo study Á Márk, M Hajdu, Z Váradi, TB Sticz, N Nagy, J Csomor, L Berczi, V Varga, ... BMC cancer 13, 1-12, 2013 | 48 | 2013 |
| Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim–Chester disease Z Váradi, R Bánusz, J Csomor, K Kállay, E Varga, G Kertész, M Csóka OncoTargets and therapy, 521-526, 2017 | 44 | 2017 |
| Activity and complexes of mTOR in diffuse large B-cell lymphomas—a tissue microarray study A Sebestyén, TB Sticz, Á Márk, M Hajdu, B Timár, K Nemes, N Nagy, ... Modern Pathology 25 (12), 1623-1628, 2012 | 35 | 2012 |
| Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL) K Nemes, A Sebestyén, Á Márk, M Hajdu, I Kenessey, T Sticz, E Nagy, ... PLoS One 8 (4), e59335, 2013 | 33 | 2013 |
| Primary alveolar rhabdomyosarcoma of the bone: two cases and review of the literature P Balogh, R Bánusz, M Csóka, Z Váradi, E Varga, Z Sápi Diagnostic Pathology 11, 1-6, 2016 | 17 | 2016 |
| In situ analysis of mTORC1/C2 and metabolism-related proteins in pediatric osteosarcoma A Mohás, I Krencz, Z Váradi, G Arató, L Felkai, DJ Kiss, D Moldvai, ... Pathology and Oncology Research 28, 2022 | 3 | 2022 |
| Diagnosis and treatment of childhood soft tissue sarcomas R Bánusz, Z Váradi, E Varga, Z Jakab, M Garami, M Csóka Magyar Onkologia 58 (1), 59-64, 2014 | 3 | 2014 |
| ALK Status Determination and Crizotinib Therapy in High Risk Neuroblastoma and Soft Tissue Sarcoma M Csoka, L Felkai, R Banusz, Z Varadi, M Garami PEDIATRIC BLOOD & CANCER 63, S259-S259, 2016 | | 2016 |
| MTOR RELATED PROTEIN EXPRESSION IN CHILDHOOD ALL M Csoka, K Nemes, A Mark, M Hajdu, Z Varadi, A Sebestyen PEDIATRIC BLOOD & CANCER 61, S256-S256, 2014 | | 2014 |
| Gyermekkori lágyrészsarcomak diagnosztikája es kezelése. R Bánusz, Z Varadi, E Varga, Z Jakab, M Garami, M Csóka | | 2014 |
| 798 Mammalian Target of Rapamycin (mTOR) Activity as a Potential Target in Human Diffuse Large B-cell Lymphomas and Hodgkin Lymphomas A Mark, M Hajdu, T Sticz, Z Varadi, N Nagy, B Timar, M Csoka, L Kopper, ... european journal of cancer, S190, 2012 | | 2012 |
| Rapamycin Sensitivity And mTor Activity in Lymphoma/Leukemia Cells Z Varadi, K Nemes, A Mark, M Csoka, A Sebestyen EUROPEAN JOURNAL OF MEDICAL RESEARCH 16, 42-42, 2011 | | 2011 |
| 9205 ORAL Mammalian Target of Rapamycin (mTOR) Activity Dependent Protein Expression and Rapamycin Sensitivity in Pediatric Acute Lymphoblastic Leukemias A Sebestven, K Nemes, A Mark, Z Váradi, M Hajdu, T Sticz, L Kopper, ... European Journal of Cancer, S641, 2011 | | 2011 |
